Published in J Assoc Acad Minor Phys on January 01, 1996
Pigment gallstones. Gastroenterology (1977) 1.51
Pigment vs cholesterol cholelithiasis: comparison of stone and bile composition. Am J Dig Dis (1974) 1.44
Identification of patients with cholesterol or pigment gallstones by discriminant analysis of radiographic features. N Engl J Med (1981) 1.28
Pigment vs cholesterol cholelithiasis: clinical and epidemiological aspects. Am J Dig Dis (1975) 1.21
Pigment gallstone disease: Summary of the National Institutes of Health--international workshop. Hepatology (1983) 1.16
Measurement of conjugated and unconjugated bilirubin in bile. II. A new thin-layer chromatographic method. J Lab Clin Med (1976) 1.15
Pigment gallstone composition in patients with hemolysis or infection/stasis. Dig Dis Sci (1986) 1.11
Unconjugated bilirubin, and the hydrolysis of conjugated bilirubin, in gallbladder bile of patients with cholelithiasis. Gastroenterology (1978) 1.11
Dilatation of severe esophageal strictures by an inflatable balloon catheter. Gastroenterology (1981) 1.09
Effects of a prostaglandin E1 derivative, SC-29333, and aspirin on gastric ionic fluxes and potential difference in dogs. J Pharmacol Exp Ther (1979) 1.08
Evaluation of radiographic lucency or opaqueness of gallstones as a means of identifying cholesterol or pigment stones. Correlation of lucency or opaqueness with calcium and mineral. Gastroenterology (1975) 1.08
Kinetic analysis of biliary lipid excretion in man and dog. J Clin Invest (1976) 1.07
Loperamide binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther (1976) 1.06
Chemistry and synthetic development of misoprostol. Dig Dis Sci (1985) 1.05
SC-29333: a potent inhibitor of canin gastric secretion. Am J Dig Dis (1976) 1.04
Marked alkaline phosphatase elevation with partial common bile duct obstruction due to calcific pancreatitis. Gastroenterology (1976) 1.04
Effects of E prostaglandins on canine gastric potential difference. Am J Dig Dis (1978) 1.03
Pigment vs cholesterol cholelithiasis: bacteriology of gallbladder stone, bile, and tissue correlated with biliary lipid analysis. Am J Dig Dis (1978) 1.01
Composition of pigmented centers of cholesterol gallstones. Hepatology (1986) 1.00
Pigment versus cholesterol cholelithiasis: identification and quantification by infrared spectroscopy. Gastroenterology (1977) 0.99
Black and brown pigment gallstones differ in microstructure and microcomposition. Hepatology (1984) 0.99
Studies on the pathogenesis of pigment gallstones in hemolytic anemia: description and characteristics of a mouse model. J Clin Invest (1980) 0.96
Gastrointestinal angiodysplasia. J Assoc Acad Minor Phys (1997) 0.94
Insights into pigment stone disease. J Lab Clin Med (1979) 0.93
Mucin glycoprotein content of human pigment gallstones. Hepatology (1983) 0.91
Hemolysis-induced gallstones in mice: increased unconjugated bilirubin in hepatic bile predisposes to gallstone formation. Gastroenterology (1981) 0.88
Azodipyrroles of unconjugated and conjugated bilirubin using diazotized ethyl anthranilate in dimethyl sulfoxide. Anal Biochem (1982) 0.87
Milk of calcium bile. Evidence that gallbladder stasis is a key factor. Dig Dis Sci (1987) 0.87
Effect of SC-29333, an inhibitor of gastric secretion, on canine gastric mucosal blood flow and serum gastrin levels. Arch Int Pharmacodyn Ther (1978) 0.87
Ultrasonic properties of gallstones. Effect of stone size and composition. Gastroenterology (1979) 0.87
The pharmacology of SC-27166: a novel antidiarrheal agent. J Pharmacol Exp Ther (1977) 0.87
Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study. Dig Dis Sci (1985) 0.87
3,3-Diphenyl-3-(2-alkyl-1,3,4-oxadiazol-5-yl)propylcycloalkylamines, a novel series of antidiarrheal agents. J Med Chem (1976) 0.86
Comparative gastric antisecretory and antiulcer effects of prostaglandin E1 and its methyl ester in animals. Prostaglandins (1975) 0.86
Inhibition of intestinal secretion in the dog: a new approach for the management of diarrheal states. J Pharmacol Exp Ther (1981) 0.85
Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1. Dig Dis Sci (1985) 0.85
Comparative cytoprotective effects against alcohol insult. Misoprostol versus cimetidine. Dig Dis Sci (1986) 0.84
The calcium ionophore A23187 stimulates glycoprotein secretion by the guinea pig gallbladder. Hepatology (1986) 0.84
Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates. Am J Pathol (1995) 0.83
Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas. Gastroenterology (1997) 0.82
Idiopathic esophageal ulceration in acquired immunodeficiency syndrome: successful treatment with misoprostol and viscous lidocaine. Am J Gastroenterol (1998) 0.82
Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man. Dig Dis Sci (1988) 0.81
Is peptic ulcer a prostaglandin deficiency disease? Hum Pathol (1986) 0.81
Effects of E prostaglandins, diphenoxylate and morphine on intestinal motility in vivo. Eur J Pharmacol (1975) 0.80
Dysphagia in a patient with Hodgkin's disease. JAMA (1980) 0.80
Inappropriate antidiuretic hormone in Hodgkin's disease. Am J Med Sci (1973) 0.80
Impedance planimetric characterization of the distal oesophagus in the Goettingen minipig. J Biomech (1996) 0.80
Misoprostol but not antacid prevents endotoxin-induced gastric mucosal injury: role of tumor necrosis factor-alpha. Dig Dis Sci (1991) 0.79
Epidemiologic pattern of esophageal cancer at an inner-city university hospital. J Assoc Acad Minor Phys (1999) 0.79
Factors affecting bilirubin excretion in patients with cholesterol or pigment gallstones. Gastroenterology (1977) 0.79
Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview. Dig Dis Sci (1985) 0.78
Effect of phenobarbital on serum and biliary parameters in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis. Dig Dis Sci (1983) 0.78
Biomechanical properties of the oesophagus damaged by endoscopic sclerotherapy. An impedance planimetric study in minipigs. Scand J Gastroenterol (1994) 0.78
Tissue distribution of 131I-labelled epidermal growth factor in the pig visualized by dynamic scintigraphy. J Endocrinol (1995) 0.78
Cyclic deposition of calcium salts during growth of cholesterol gallstones. Scan Electron Microsc (1985) 0.78
Systemic treatment with recombinant human epidermal growth factor accelerates healing of sclerotherapy-induced esophageal ulcers and prevents esophageal stricture formations in pigs. Dig Dis Sci (1994) 0.78
Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer. Dig Dis Sci (1986) 0.77
Refractory peptic ulcers. J Assoc Acad Minor Phys (1992) 0.77
Gastric antisecretory actions of (15S)-15-methyl prostaglandin E2 methyl ester and natural prostaglandin E2 in rhesus monkeys. Prostaglandins (1976) 0.77
Gastrointestinal toxicity of over-the-counter analgesics. Am J Gastroenterol (1998) 0.77
Chronic systemic treatment with epidermal growth factor induces hypergastrinaemia in Goettingen minipigs. Scand J Gastroenterol (1995) 0.77
Misoprostol prevents damage to the gastric mucosa by stabilizing the mast cells. Prostaglandins (1987) 0.77
Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats. Dig Dis Sci (1995) 0.76
Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage. A double-blind endoscopic study in human subjects. Gastrointest Endosc (1986) 0.76
Pigment gallstone composition in cirrhotic and noncirrhotic subjects. Am J Dig Dis (1978) 0.76
Hepatitis and glomerulonephritis in secondary syphilis. J Assoc Acad Minor Phys (1991) 0.76
Antidiarrheal and central nervous system activities of SC-27166 (2-[3 - 5 - methyl - 1, 3, 4 - oxadiazol - 2 - yl) - 3, 3 - diphenylpropyl] - 2 - azabicyclo [2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther (1977) 0.76
Epidermal growth factor attenuates the sclerotherapy-induced biomechanical properties of the oesophagus. An experimental study in minipigs. Scand J Gastroenterol (1995) 0.76
Synthesis and gastric antisecretory properties of 15-deoxy-16-hydroxyprostaglandin E analogues. J Med Chem (1977) 0.75
Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa. Clin Invest Med (1987) 0.75
Hypertension: a multietiological disease requires a multifactorial approach. J Assoc Acad Minor Phys (1995) 0.75
Omega-3 fatty acids and bowel cancer. Gastroenterology (1993) 0.75
Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury? Am J Gastroenterol (1996) 0.75
Naloxone reversal of drug-induced diarrhea in mice. Arch Int Pharmacodyn Ther (1979) 0.75
Synthesis and biological evaluation of omega-homologues of prostaglandin E1. J Med Chem (1976) 0.75
Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs. J Assoc Acad Minor Phys (1992) 0.75
The apparent association constant of calcium and bilirubinate ions in Triton X-100 micelles. J Assoc Acad Minor Phys (1989) 0.75
Update on acid-peptic disorders. J Assoc Acad Minor Phys (1992) 0.75
Drugs for treatment of peptic ulcers. J Assoc Acad Minor Phys (1992) 0.75
Nonsteroidal anti-inflammatory drugs and acute upper gastrointestinal bleeding: a prospective study. J Assoc Acad Minor Phys (1991) 0.75
Esophageal candidoma in a patient with acquired immunodeficiency syndrome. J Assoc Acad Minor Phys (1998) 0.75
Future treatment of peptic ulcer: is there room for anti-infective drugs? J Physiol Pharmacol (1993) 0.75
Influence of the position of the side chain hydroxy group on the gastric antisecretory and antiulcer actions of E1 prostaglandin analogs. Prostaglandins (1975) 0.75
Palliation of esophageal cancer with a self-expanding, silicone-covered stent and a technique for stent retrieval. J Assoc Acad Minor Phys (1996) 0.75
Use and safety of aspirin in the chemoprevention of colorectal cancer. J Assoc Acad Minor Phys (1998) 0.75
Highlights of the ninth annual scientific meeting of the Association for Academic Minority Physicians, 1995. J Assoc Acad Minor Phys (1996) 0.75
Gastric antiulcer and antisecretory effects of carbenoxolone, aldosterone and desoxycorticosterone in rats. Arch Int Pharmacodyn Ther (1979) 0.75
Interaction of hemolysis and genotype on ionized calcium in bile of mice with hemolysis-induced gallstones. Gastroenterology (1984) 0.75
Highlights of the 14th Annual Scientific Meeting of the Association for Academic Minority Physicians, 2000. J Assoc Acad Minor Phys (2001) 0.75
Nasopancreatic drainage: a novel approach for treating internal pancreatic fistulas and pseudocysts. J Assoc Acad Minor Phys (1996) 0.75
Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage. J Rheumatol Suppl (1990) 0.75
Viral replication in chronic hepatitis B virus infection. Dig Dis Sci (1983) 0.75
Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury. Int J Clin Pharmacol Res (1989) 0.75
Antiulcer drugs and gastric mucosal integrity. Effects of misoprostol, 16,16-dimethyl PGE2, and cimetidine on hemodynamics and metabolic rate in canine gastric mucosa. Dig Dis Sci (1992) 0.75
Pigment gallstone disease. Semin Liver Dis (1983) 0.75
Canine gastrointestinal motility effects of prostaglandin F2 alpha in vivo. Arch Int Pharmacodyn Ther (1979) 0.75
Is cytoprotection by misoprostol against ethanol-induced gastric mucosal injury in man mediated by somatostatin? Prostaglandins (1987) 0.75
Noncirrhotic portal hypertension in the adult: case report and review of the literature. J Assoc Acad Minor Phys (1998) 0.75
Synthesis and gastric antisecretory properties of 4,5-unsaturated derivatives of 15-deoxy-16-hydroxy-16-methylprostaglandin E1. J Med Chem (1983) 0.75